None listed
Conditions
Interventions
Drug : In group M, initiate the initial continuous infusion dose at 5 mcg / kg / min and maintain TOF1-2 under TOF monitoring. Reduce by 0.5 mg for TOF 0 and increase by 0.5 mg for TOF 3-4. In group D
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult patients with ASA class I-IV (aged 19-70 years) 2) Patients diagnosed with atrial fibrillation and underwent RFCA for the first time under general anesthesia
Exclusion criteria
Exclusion criteria: 1) Children (under 19 years old) 2) Patients who were diagnosed with atrial fibrillation and underwent RFCA 3) Patients with a high likelihood of lung aspiration 4) Patient with unstable vital signs 5) Patients with liver, kidney disease 6) Patients with metabolic diseases 7) Emergency surgery 8) Pregnant women,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate according to degree of muscle relaxation | — |
Secondary
| Measure | Time frame |
|---|---|
| Continuous variable: Heart Rate, Blood Pressure, Bispectral index(BIS);operation time;Self respiration recovery number of times;Operator satisfaction score | — |
Countries
Korea, Republic of
Contacts
Public ContactJin hee Ahn
Samsung Medical Center
Outcome results
None listed